3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33574724 | Managing Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors Through Co-Targeting MEK/ERK Signaling. | 2021 | 1 |
2 | 31821539 | ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor-mutant non-small cell lung cancer cells to osimertinib. | 2020 Mar 15 | 1 |
3 | 29967248 | A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways. | 2018 Nov 15 | 2 |